Extracellular matrix roles in cardiorenal fibrosis: Potential therapeutic targets for CVD and CKD in the elderly

Hiroe Toba, Merry L. Lindsey

Research output: Contribution to journalReview article

3 Citations (Scopus)

Abstract

Whereas hypertension, diabetes, and dyslipidemia are age-related risk factors for cardiovascular disease (CVD) and chronic kidney disease (CKD), aging alone is an independent risk factor. With advancing age, the heart and kidney gradually but significantly undergo inflammation and subsequent fibrosis, which eventually results in an irreversible decline in organ physiology. Through cardiorenal network interactions, cardiac dysfunction leads to and responds to renal injury, and both facilitate aging effects. Thus, a comprehensive strategy is needed to evaluate the cardiorenal aging network. Common hallmarks shared across systems include extracellular matrix (ECM) accumulation, along with upregulation of matrix metalloproteinases (MMPs) including MMP-9. The wide range of MMP-9 substrates, including ECM components and inflammatory cytokines, implicates MMP-9 in a variety of pathological and age-related processes. In particular, there is strong evidence that inflammatory cell-derived MMP-9 exacerbates cardiorenal aging. This review explores the potential therapeutic targets against CVD and CKD in the elderly, focusing on ECM and MMP roles.

Original languageEnglish (US)
Pages (from-to)99-120
Number of pages22
JournalPharmacology and Therapeutics
Volume193
DOIs
StatePublished - Jan 2019

Fingerprint

Matrix Metalloproteinase 9
Chronic Renal Insufficiency
Extracellular Matrix
Fibrosis
Cardiovascular Diseases
Matrix Metalloproteinases
Kidney
Therapeutics
Dyslipidemias
Up-Regulation
Cytokines
Hypertension
Inflammation
Wounds and Injuries

Keywords

  • Cardiorenal aging
  • Extracellular matrix
  • Fibrosis
  • Inflammaging
  • Matrix metalloproteinase-9

ASJC Scopus subject areas

  • Pharmacology
  • Pharmacology (medical)

Cite this

Extracellular matrix roles in cardiorenal fibrosis : Potential therapeutic targets for CVD and CKD in the elderly. / Toba, Hiroe; Lindsey, Merry L.

In: Pharmacology and Therapeutics, Vol. 193, 01.2019, p. 99-120.

Research output: Contribution to journalReview article

@article{4964c32f190e418291ac5340d3cff50b,
title = "Extracellular matrix roles in cardiorenal fibrosis: Potential therapeutic targets for CVD and CKD in the elderly",
abstract = "Whereas hypertension, diabetes, and dyslipidemia are age-related risk factors for cardiovascular disease (CVD) and chronic kidney disease (CKD), aging alone is an independent risk factor. With advancing age, the heart and kidney gradually but significantly undergo inflammation and subsequent fibrosis, which eventually results in an irreversible decline in organ physiology. Through cardiorenal network interactions, cardiac dysfunction leads to and responds to renal injury, and both facilitate aging effects. Thus, a comprehensive strategy is needed to evaluate the cardiorenal aging network. Common hallmarks shared across systems include extracellular matrix (ECM) accumulation, along with upregulation of matrix metalloproteinases (MMPs) including MMP-9. The wide range of MMP-9 substrates, including ECM components and inflammatory cytokines, implicates MMP-9 in a variety of pathological and age-related processes. In particular, there is strong evidence that inflammatory cell-derived MMP-9 exacerbates cardiorenal aging. This review explores the potential therapeutic targets against CVD and CKD in the elderly, focusing on ECM and MMP roles.",
keywords = "Cardiorenal aging, Extracellular matrix, Fibrosis, Inflammaging, Matrix metalloproteinase-9",
author = "Hiroe Toba and Lindsey, {Merry L.}",
year = "2019",
month = "1",
doi = "10.1016/j.pharmthera.2018.08.014",
language = "English (US)",
volume = "193",
pages = "99--120",
journal = "Pharmacology and Therapeutics",
issn = "0163-7258",
publisher = "Elsevier Inc.",

}

TY - JOUR

T1 - Extracellular matrix roles in cardiorenal fibrosis

T2 - Potential therapeutic targets for CVD and CKD in the elderly

AU - Toba, Hiroe

AU - Lindsey, Merry L.

PY - 2019/1

Y1 - 2019/1

N2 - Whereas hypertension, diabetes, and dyslipidemia are age-related risk factors for cardiovascular disease (CVD) and chronic kidney disease (CKD), aging alone is an independent risk factor. With advancing age, the heart and kidney gradually but significantly undergo inflammation and subsequent fibrosis, which eventually results in an irreversible decline in organ physiology. Through cardiorenal network interactions, cardiac dysfunction leads to and responds to renal injury, and both facilitate aging effects. Thus, a comprehensive strategy is needed to evaluate the cardiorenal aging network. Common hallmarks shared across systems include extracellular matrix (ECM) accumulation, along with upregulation of matrix metalloproteinases (MMPs) including MMP-9. The wide range of MMP-9 substrates, including ECM components and inflammatory cytokines, implicates MMP-9 in a variety of pathological and age-related processes. In particular, there is strong evidence that inflammatory cell-derived MMP-9 exacerbates cardiorenal aging. This review explores the potential therapeutic targets against CVD and CKD in the elderly, focusing on ECM and MMP roles.

AB - Whereas hypertension, diabetes, and dyslipidemia are age-related risk factors for cardiovascular disease (CVD) and chronic kidney disease (CKD), aging alone is an independent risk factor. With advancing age, the heart and kidney gradually but significantly undergo inflammation and subsequent fibrosis, which eventually results in an irreversible decline in organ physiology. Through cardiorenal network interactions, cardiac dysfunction leads to and responds to renal injury, and both facilitate aging effects. Thus, a comprehensive strategy is needed to evaluate the cardiorenal aging network. Common hallmarks shared across systems include extracellular matrix (ECM) accumulation, along with upregulation of matrix metalloproteinases (MMPs) including MMP-9. The wide range of MMP-9 substrates, including ECM components and inflammatory cytokines, implicates MMP-9 in a variety of pathological and age-related processes. In particular, there is strong evidence that inflammatory cell-derived MMP-9 exacerbates cardiorenal aging. This review explores the potential therapeutic targets against CVD and CKD in the elderly, focusing on ECM and MMP roles.

KW - Cardiorenal aging

KW - Extracellular matrix

KW - Fibrosis

KW - Inflammaging

KW - Matrix metalloproteinase-9

UR - http://www.scopus.com/inward/record.url?scp=85052938808&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85052938808&partnerID=8YFLogxK

U2 - 10.1016/j.pharmthera.2018.08.014

DO - 10.1016/j.pharmthera.2018.08.014

M3 - Review article

C2 - 30149103

AN - SCOPUS:85052938808

VL - 193

SP - 99

EP - 120

JO - Pharmacology and Therapeutics

JF - Pharmacology and Therapeutics

SN - 0163-7258

ER -